Welcome to LookChem.com Sign In|Join Free
  • or
1-Piperazinecarboxaldehyde, 4-(2-pyrimidinyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

88268-16-0

Post Buying Request

88268-16-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88268-16-0 Usage

Common uses

Synthesis of medicinal drugs in the pharmaceutical industry

Chemical class

Piperazine derivatives

Potential biological activities

Antitumor, antibacterial, and anti-inflammatory properties

Therapeutic potential

Treatment of various medical conditions, particularly in cancer research

Promise in drug development

New drugs for the treatment of infectious diseases and inflammatory disorders

Future implications

Discovery of novel pharmaceuticals with significant therapeutic benefits.

Check Digit Verification of cas no

The CAS Registry Mumber 88268-16-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,2,6 and 8 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 88268-16:
(7*8)+(6*8)+(5*2)+(4*6)+(3*8)+(2*1)+(1*6)=170
170 % 10 = 0
So 88268-16-0 is a valid CAS Registry Number.

88268-16-0Downstream Products

88268-16-0Relevant academic research and scientific papers

Complementation of biotransformations with chemical C-H oxidation: Copper-catalyzed oxidation of tertiary amines in complex pharmaceuticals

Genovino, Julien,Luetz, Stephan,Sames, Dalibor,Toure, B. Barry

supporting information, p. 12346 - 12352 (2013/09/23)

The isolation, quantitation, and characterization of drug metabolites in biological fluids remain challenging. Rapid access to oxidized drugs could facilitate metabolite identification and enable early pharmacology and toxicity studies. Herein, we compared biotransformations to classical and new chemical C-H oxidation methods using oxcarbazepine, naproxen, and an early compound hit (phthalazine 1). These studies illustrated the low preparative efficacy of biotransformations and the inability of chemical methods to oxidize complex pharmaceuticals. We also disclose an aerobic catalytic protocole (CuI/air) to oxidize tertiary amines and benzylic CH's in drugs. The reaction tolerates a broad range of functionalities and displays a high level of chemoselectivity, which is not generally explained by the strength of the C-H bonds but by the individual structural chemotype. This study represents a first step toward establishing a chemical toolkit (chemotransformations) that can selectively oxidize C-H bonds in complex pharmaceuticals and rapidly deliver drug metabolites.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 88268-16-0